Expert advisory firm Newport Board Group, LLC continues to expand locally, announcing today the admission of Martin Rosendale, a life sciences entrepreneur and executive as a member of the LLC and Partner in its Mid-Atlantic practice.
Why and how AMAZON will disrupt and dominate health care in 2025 – Will AMAZON buy Roche? | LinkedIn
A vision on healthcare and medicine in 2025; customer & patient experiences will change dramatically due to AI, IoT, Cloud driven disruption:
It’s time for your annual checkup! A phlebotomist will conveniently visit you at home in the early morning and take your blood (while you are lying relaxed, since it makes a difference to your metabolome if you are lying or sitting), possibly also collecting samples of saliva as well as urine and stool samples your intelligent toilet was sampling and preserving for later microbiome, metabolome, proteome analytics . The service for onsite blood sampling and the technology is there; see IggBo video.
Mayo Clinic and United Therapeutics Corp. can start construction on the foundation for their proposed lung-restoration center at Mayo’s Southside campus.
Imagine that Baltimore’s street lights automatically came on when they sensed someone was near, collected data about air quality and even alerted police at the sound of a gunshot.
We are feeling so #grateful! #ThankYou Cheryl C. Kagan, Hans Riemer, Carla M. Merritt, Karen McManus, Chris Van Hollen, George Leventhal, Megan Howie, @Judy Costello, @Richard Bendis, C. David Pauza, Selina Yuanyuan Milligan 樊媛媛, Virginia M Crews, Martin Rosendale, Ben Woodard, Susan Prince, Tom Hucker, Tom Wallace, Lynne Stein Benzion, CEcD, and many more for celebrating a monumental #Maryland move to 24000sqft lab+office, where we’ll launch a #HIV functional cure!
The best Data Scientists see in a slew of data what matters, communicate why it matters, and instruct others about how strategy and operations must change to address what matters.
How can Johnson & Johnson Innovation (JJI) help you reach your goals? We know what you, the innovator, need to get your science to patients. It is because of you that JJI created regional centers that host a diverse team of science and transaction experts whose goal is to find high potential early-stage innovation and, if on strategy and a fit for Johnson & Johnson, create customized deal structures to help accelerate the science to the patient.
Every marketer wants the perfect story to tell. But if you’re in medicine, you don’t want it to be about yourself.
Earlier this year, vascular surgeon John Martin was testing a pocket-sized ultrasound device developed by Butterfly Network, a startup based in Guilford, Connecticut, that he’d just joined as chief medical officer.
1ST Biotherapeutics, Inc. (1ST Bio), a private Korean biotech company, and Neuraly Inc., a startup from Johns Hopkins School of Medicine, today announced a collaboration to co-develop novel brain penetrant c-Abl inhibitors for Parkinson’s disease. Recent research has shown that inhibitors to c-Abl could slow the progression of Parkinson’s disease. Parkinson’s disease, a chronic and progressive movement disorder, is the second most common neurodegenerative disease, affecting nearly one million people in the United States.
A plan to build 12M SF of mixed-use development on a 300-acre site near the Food and Drug Administration’s HQ in Montgomery County has been in the works for nearly a decade, and the developer feels confident it can break ground in a matter of months.